Compare with Psomagen Inc Shs Korean Depositary Receipt Repr 1 Sh

Key stats

Profile

Psomagen, Inc. engages in the provision of genomic, transcriptomic, and proteomic analysis to research programs and operations, serving academic, pharma, biotech, government, and industry. It develops technologies such as short and long-read next-generation sequencing (NGS), Sanger (CE) sequencing, microarray, single-cell omics, metagenomics and microbiome, spatial biology, bioinformatics, and biomarker discovery. The company was founded on December 2, 2004 and is headquartered in Rockville, MD.

Financials

Performance

Revenue to profit conversion

Debt level and coverage

Earnings

Next:—

Technicals

Summarizing what the indicators are suggesting.

Oscillators

Neutral

SellBuy

Strong sellStrong buy